Sunday, May 24, 2015

Policy to Promote Bulk Drug Manufacturing to be Formulated: Minister

New Delhi: The government is examining recommendations of a committee set up to study issues related to critical active pharmaceutical ingredients (APIs) so as to formulate a policy for promoting their manufacturing in the country.

"The Government has taken various measures to promote 'Make in India' initiative in pharmaceutical sector," and had constituted a committee under the chairmanship of Secretary, Department of Health Research in this direction, Minister of Chemicals and Fertilisers Ananth Kumar said in a reply to the Lok Sabha.

"The committee has recommended establishment of Mega Parks for APIs with common facilities such as common effluent treatment plants, testing facilities, captive power plants/assured power supply by state systems, common utilities/services such as storage, testing laboratories, IPR management, designing, guest houses/accommodation etc. maintained by a separate special purpose vehicles (SPV)," he said.

The recommendations are being examined for formulation of a policy for promotion of manufacturing of bulk drugs, Mr Kumar said.


Follow me on twitter for more Daily updates

                     For more reports from Asia  www.search.dowellresearch.com

                      For any Market research consulting services  www.dowellresearch.com


No comments:

Post a Comment

Followers

Total Pageviews